Comparison

ACG416B European Partner

Item no. TMO-T40903-5mg
Manufacturer TargetMol
CASRN 795316-15-3
Amount 5 mg
Quantity options 100 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Smiles [Br-].[Br-].CN(c1ccccc1)c1cc[n+](Cc2cccc(c2)-c2cccc(C[n+]3ccc(cc3)N(C)c3ccccc3)c2)cc1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
708.542
Description
ACG416B (compound 18) exhibits formidable inhibitory effects on choline kinase (ChoK), with an IC 50 measurement of 0.4 μM. Notably, ACG416B demonstrates superior inhibitory activities against HT-29 human colon cancer cells, resulting in pronounced antiproliferative effects.
Pathways
Others
Bioactivity
ACG416B (compound 18) is a potent inhibitor of ChoK (choline kinase) with an IC 50 of 0.4 μM. ACG416B renders higher ChoK inhibitory and antiproliferative activities against the HT-29 human colon cancer cell.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close